Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults [version 2; peer review: 2 approved]
Background: Hyperuricemia is a pathological condition associated with risk factors of cardiovascular disease. In this study, three genetic polymorphisms were genotyped as predisposing factors of hyperuricemia. Methods: A total of 860 Mexicans (129 cases and 731 controls) between 18 and 25 years of a...
Main Authors: | Juan Manuel Vargas-Morales, Martha Guevara-Cruz, Celia Aradillas-García, Lilia G. Noriega, Armando Tovar, Jorge Alejandro Alegría-Torres |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2021-09-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/10-217/v2 |
Similar Items
-
Progress on the role of ABCG2 and SLC2A9 in the onset of hyperuricemia and gout
by: YANG Lijuan, DONG Qiumei, WU Hao
Published: (2023-09-01) -
ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population
by: Jia Liu, et al.
Published: (2020-03-01) -
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
by: Robert Eckenstaler, et al.
Published: (2021-06-01) -
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
by: Zheng Dong, et al.
Published: (2020-01-01) -
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01)